Why Credo Technology (CRDO) Stock Is Up Today

2026-10-26

Investivoq PriceTracker

Credo Technology Group Holding Ltd (CRDO) is up 5.8% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely explanation is a mix of sector strength and continued optimism around Credo’s role in AI data-center connectivity. There does not appear to be a major new company-specific filing or earnings release today, so the move could be because investors rotated back into semiconductor and networking names after a recent pullback while still responding to Credo’s recent product announcements for higher-speed AI infrastructure.

Details:

Credo recently introduced a short-reach micro-emitter optics standardization effort aimed at AI data-center scale-up and scale-out applications, reinforcing its push into next-generation connectivity products.

In September, the company also unveiled 224G-based 1.6T optical transceivers designed for AI network infrastructure, which kept attention on its optical growth opportunity.

The company’s most recent 8-K in mid-October covered annual meeting voting results rather than a negative operational update, which suggests today’s gain was not driven by the removal of a fresh company-specific overhang.

Broader chip and AI-linked shares moved higher on October 26 as investors returned to the group, which likely helped lift Credo along with other semiconductor names.

Sources:

Credo Investor Relations, SEC, AP News

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CRDO Insider Trading Activity

$CRDO insiders have traded $CRDO stock on the open market 329 times in the past 6 months. Of those trades, 0 have been purchases and 329 have been sales.

Here’s a breakdown of recent trading of $CRDO stock by insiders over the last 6 months:

CHI FUNG CHENG (Chief Technology Officer) has made 0 purchases and 194 sales selling 431,102 shares for an estimated $89,714,478.
YAT TUNG LAM (Chief Operating Officer) has made 0 purchases and 57 sales selling 361,439 shares for an estimated $77,263,875.
WILLIAM JOSEPH BRENNAN (Pres & Chief Executive Officer) has made 0 purchases and 44 sales selling 103,322 shares for an estimated $17,730,053.
DANIEL W. FLEMING (Chief Financial Officer) has made 0 purchases and 26 sales selling 55,160 shares for an estimated $13,456,884.
JAMES LAUFMAN (Chief Legal Officer, Secretary) has made 0 purchases and 4 sales selling 20,000 shares for an estimated $4,386,475.
CLYDE HOSEIN sold 3,451 shares for an estimated $905,283
SYLVIA ACEVEDO sold 2,208 shares for an estimated $465,888
PANTAS SUTARDJA, sold 1,540 shares for an estimated $326,818
FARIBA DANESH sold 1,100 shares for an estimated $259,979

To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.

$CRDO Hedge Fund Activity

We have seen 608 institutional investors add shares of $CRDO stock to their portfolio, and 377 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JENNISON ASSOCIATES LLC added 2,408,196 shares (+974.6%) to their portfolio in Q2 2026, for an estimated $654,908,902
WELLINGTON MANAGEMENT GROUP LLP removed 2,066,529 shares (-60.6%) from their portfolio in Q2 2026, for an estimated $561,992,561
BLACKROCK, INC. removed 2,059,560 shares (-10.4%) from their portfolio in Q2 2026, for an estimated $560,097,342
ALLIANCEBERNSTEIN L.P. removed 1,717,449 shares (-86.5%) from their portfolio in Q2 2026, for an estimated $467,060,255
HRT FINANCIAL LP added 1,387,796 shares (+inf%) to their portfolio in Q2 2026, for an estimated $377,411,122
QUBE RESEARCH & TECHNOLOGIES LTD added 1,342,314 shares (+inf%) to their portfolio in Q2 2026, for an estimated $365,042,292
POINT72 ASSET MANAGEMENT, L.P. removed 1,326,467 shares (-17.7%) from their portfolio in Q2 2026, for an estimated $360,732,700

To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

$CRDO Congressional Stock Trading

Members of Congress have traded $CRDO stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $CRDO stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 07/02, 06/30.

To track congressional stock trading, check out Investivoq's congressional trading dashboard. You can access data on congressional stock trades through the Investivoq API Congress trades endpoint.

$CRDO Analyst Ratings

Wall Street analysts have issued reports on $CRDO in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Rothschild & Co issued a "Buy" rating on 05/01/2026

To track analyst ratings and price targets for $CRDO, check out Investivoq's $CRDO forecast page.

$CRDO Price Targets

Multiple analysts have issued price targets for $CRDO recently. We have seen 12 analysts offer price targets for $CRDO in the last 6 months, with a median target of $272.5.

Here are some recent targets:

Vivek Arya from B of A Securities set a target price of $340.0 on 06/23/2026
Tore Svanberg from Stifel set a target price of $350.0 on 06/22/2026
Mark Lipacis from Evercore ISI Group set a target price of $325.0 on 06/22/2026
N. Quinn Bolton from Needham set a target price of $275.0 on 06/02/2026
Vijay Rakesh from Mizuho set a target price of $290.0 on 06/02/2026
Mike Genovese from Rosenblatt set a target price of $215.0 on 06/02/2026
Blayne Curtis from Jefferies set a target price of $270.0 on 06/02/2026

This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.